LLY

728.67

-2.49%↓

JNJ

153.66

+0.1%↑

ABBV

182.32

-1.03%↓

NVO

68.3

+0.57%↑

UNH

305

-5.37%↓

LLY

728.67

-2.49%↓

JNJ

153.66

+0.1%↑

ABBV

182.32

-1.03%↓

NVO

68.3

+0.57%↑

UNH

305

-5.37%↓

LLY

728.67

-2.49%↓

JNJ

153.66

+0.1%↑

ABBV

182.32

-1.03%↓

NVO

68.3

+0.57%↑

UNH

305

-5.37%↓

LLY

728.67

-2.49%↓

JNJ

153.66

+0.1%↑

ABBV

182.32

-1.03%↓

NVO

68.3

+0.57%↑

UNH

305

-5.37%↓

LLY

728.67

-2.49%↓

JNJ

153.66

+0.1%↑

ABBV

182.32

-1.03%↓

NVO

68.3

+0.57%↑

UNH

305

-5.37%↓

Search

Minerva Neurosciences Inc

Open

1.41 4.44

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.32

Max

1.45

Schlüsselkennzahlen

By Trading Economics

KGV

Branchendurchschnitt

7

56.602

Angestellte

8

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+262.32% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.6M

8.3M

Vorheriger Eröffnungskurs

-3.03

Vorheriger Schlusskurs

1.41

Minerva Neurosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Mai 2025, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

PNC to Buy Private-Equity Agent Aqueduct Capital

20. Mai 2025, 20:50 UTC

Ergebnisse

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20. Mai 2025, 23:48 UTC

Akquisitionen, Fusionen, Übernahmen

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20. Mai 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20. Mai 2025, 23:39 UTC

Market Talk

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20. Mai 2025, 23:08 UTC

Market Talk

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20. Mai 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20. Mai 2025, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20. Mai 2025, 22:44 UTC

Top News

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

20. Mai 2025, 22:20 UTC

Top News

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20. Mai 2025, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q Adj EPS 36c >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q EPS 10c >JHX

20. Mai 2025, 21:44 UTC

Ergebnisse

James Hardie Industries 4Q Sales $972M >JHX

20. Mai 2025, 20:52 UTC

Top News

Elon Musk to Cut Back Political Spending -- 3rd Update

20. Mai 2025, 20:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. Mai 2025, 20:52 UTC

Market Talk

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20. Mai 2025, 20:30 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20. Mai 2025, 20:28 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20. Mai 2025, 20:23 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20. Mai 2025, 20:22 UTC

Ergebnisse

XP 1Q Adj EPS BRL2.29 >XP

20. Mai 2025, 20:22 UTC

Ergebnisse

XP 1Q Rev BRL4.345B >XP

20. Mai 2025, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20. Mai 2025, 20:20 UTC

Top News

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20. Mai 2025, 20:19 UTC

Akquisitionen, Fusionen, Übernahmen

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20. Mai 2025, 20:11 UTC

Top News

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20. Mai 2025, 20:09 UTC

Ergebnisse

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Peer-Vergleich

Kursveränderung

Minerva Neurosciences Inc Prognose

Kursziel

By TipRanks

262.32% Vorteil

12-Monats-Prognose

Durchschnitt 5 USD  262.32%

Hoch 5 USD

Tief 5 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Minerva Neurosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Finanzen

$

Über Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.